Kala Bio KALA
NASDAQ KALA
$0.42 -0.01 (-2.37%)
As of: Oct 1, 2026 · 3:59 PM EDT

Kala Bio (KALA) Accounts Payables (2016 - 2026)

Updated

Kala Bio (KALA) posted Accounts Payables of $1.14 million for Q2 2026, up 73.6% from $658,000 a year earlier and up 9.4% from the prior quarter.

Analysis

Kala Bio (KALA) Accounts Payables (2016 - 2026) Analysis & Trends

At the end of FY2025, Kala Bio's Accounts Payables came in at $986,000, up 57.0% from FY2024.

  • Annual Accounts Payables shows a five-year compound annual growth rate of -10.6% (FY2020 to FY2025).
  • In prior years, Kala Bio's Accounts Payables was $628,000 in FY2024 (-31.7%), $919,000 in FY2023 (-67.5%), $2.83 million in FY2022 (-42.2%) and $4.9 million in FY2021 (+184.2%).
  • The Q2 2026 figure stands as the highest quarterly Accounts Payables since Q4 2022.
  • On a year-over-year basis, Accounts Payables has increased in each of the last four quarters, with growth averaging 19.6% over the last eight quarters.
  • The strongest year-over-year quarter for Accounts Payables in the past five years was Q2 2022, with growth of 270.7%; the weakest was Q2 2023, with a decline of 92.8%.
  • According to Business Quant data, Accounts Payables for the three prior quarters was $1.04 million (Q1 2026), $986,000 (Q4 2025) and $917,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Kala Bio 6.57 Mn 6.57 Mn - 1.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.14 Mn
Mar 31, 2026 1.04 Mn
Dec 31, 2025 986,000.00
Sep 30, 2025 917,000.00
Jun 30, 2025 658,000.00
Mar 31, 2025 931,000.00
Dec 31, 2024 628,000.00
Sep 30, 2024 711,000.00
Jun 30, 2024 665,000.00
Mar 31, 2024 732,000.00
Dec 31, 2023 919,000.00
Sep 30, 2023 787,000.00
Jun 30, 2023 760,000.00
Mar 31, 2023 997,000.00
Dec 31, 2022 2.83 Mn
Sep 30, 2022 7.35 Mn
Jun 30, 2022 10.54 Mn
Mar 31, 2022 6.22 Mn
Dec 31, 2021 4.90 Mn
Sep 30, 2021 5.85 Mn
API Access

Kala Bio Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=KALA&period=max&api_key=YOUR_API_KEY